ACM
GSK icon

Aquatic Capital Management’s GSK GSK Stock Holding History

Aquatic Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$335K Sell
6,062
-351,755
-98% -$19.1M 0.01% 868
2025
Q4 		$17.5M Buy
357,817
+189,342
+112% +$8.83M 0.5% 46
2025
Q3 		$7.27M Sell
168,475
-261,990
-61% -$10.2M 0.13% 188
2025
Q2 		$16.5M Buy
430,465
+97,764
+29% +$3.74M 0.33% 79
2025
Q1 		$12.9M Sell
332,701
-91,095
-21% -$3.33M 0.33% 71
2024
Q4 		$14.3M Buy
423,796
+258,096
+156% +$9.29M 0.39% 63
2024
Q3 		$6.77M Buy
165,700
+57,800
+54% +$2.36M 0.18% 146
2024
Q2 		$4.15M Buy
107,900
+49,000
+83% +$2.06M 0.15% 139
2024
Q1 		$2.53M Sell
58,900
-18,100
-24% -$746K 0.08% 224
2023
Q4 		$2.85M Sell
77,000
-2,700
-3% -$96.9K 0.07% 255
2023
Q3 		$2.89M Buy
79,700
+6,900
+9% +$245K 0.12% 181
2023
Q2 		$2.6M Buy
+72,800
New +$2.61M 0.14% 161
2022
Q4 		– Sell
-30,200
Closed -$889K – 1547
2022
Q3 		$889K Buy
30,200
+21,800
+260% +$826K 0.09% 293
2022
Q2 		$457K Buy
8,400
+7,840
+1,400% +$433K 0.15% 173
2022
Q1 		$30K Buy
+560
New +$30.4K 0.04% 390

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Aquatic Capital Management's GSK Position: Q1 2026 in Review

Aquatic Capital Management reduced its GSK (GSK) stake by 98% in Q1 2026, selling an estimated $19.1M and leaving 6,062 shares worth $335K. The position accounts for 0.01% of the portfolio, ranked #868.

Aquatic Capital Management first reported a position in GSK in Q1 2022 and has held it in 15 quarters since. The position peaked at $17.5M in Q4 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Aquatic Capital Management held 6,062 shares of GSK worth $335K as of Q1 2026.
  • Aquatic Capital Management sold 351,755 GSK shares in Q1 2026, an estimated $19.1M.
  • GSK made up 0.01% of Aquatic Capital Management's portfolio in Q1 2026, its #868 holding.
  • Aquatic Capital Management first reported a position in GSK in Q1 2022 and has held it in 15 quarters since.
  • Aquatic Capital Management's GSK position peaked at $17.5M in Q4 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.